Male Infertility Market size is assessed at USD 4.4 billion in 2024 and is set to exceed USD 8.4 billion by the end of 2037, growing at over 4.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of male infertility is estimated at USD 4.6 billion.
The male infertility market is poised to witness significant growth owing to increased acceptance of male infertility as a medical condition. The shift in societal attitudes has led to a surge in demand for treatments, diagnostics tests, and support services. As the dissemination of information becomes easier due to rising digitization, more men and couples will become educated about male infertility, further boosting the male infertility market growth.
The World Health Organization (WHO) states low sperm count, abnormal morphology and motility of sperm, and issues in ejaculation are the most common issues for male infertility. Male infertility can be categorized into primary and secondary infertility i.e. primary infertility is when a male has never impregnated a fertile female and secondary infertility is when the male has impregnated a female prior but is unable to do so for the second term. As male infertility cases rise due to unhealthy diets, increasing stress levels, and sedentary lifestyles, the demand for specialized male fertility care is projected to boom.
An Oxford Academic paper estimated male infertility affects 7% of all men. The increased media coverage on news outlets and social media platforms has managed to dispel misconceptions about male infertility. Additionally, celebrity advocacy such as from Gordon Ramsay, Mark Zuckerberg, John Legend, etc., has led to greater penetration in dispelling stigmas associated with male infertility. The percentage of males undergoing fertility tests increases as fertility care improves globally which leads to the remarkable growth of the market revenue share.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.8% |
|
Base Year Market Size (2024) |
USD 4.4 billion |
|
Forecast Year Market Size (2037) |
USD 8.4 billion |
|
Regional Scope |
|
Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Store, Online Pharmacies, Others)
Hospital pharmacies segment is anticipated to hold male infertility market share of over 31% by the end of 2037. The revenue growth of the segment is attributed to its significance as a primary distribution channel for essential medication and supplies. The number of pharmacies offering fertility care products has increased as the market sees growth leading to greater accessibility. In June 2024, NLM published a report on the rising demand for urologists and male fertility care. The report estimates around over 500000 men require reproductive urologist care annually leading to the rising demands for fertility care in men. Additionally, the product offerings to care for male infertility are expanding leading to greater footfall in hospital pharmacies for sell of medications such as supplements, antibiotics, hormonal therapies, and fertility drugs. The segment’s growth is projected to continue as an increasing number of males seek fertility care in hospitals leading to greater sales of male fertility care products in hospital pharmacies.
Retail pharmacies and drug stores are poised to have a considerable revenue growth during the forecast period. This segment is a vital distribution channel for male infertility products providing patients with convenient access to medications, supplements, and over the counter remedies. Retail pharmacies and drug stores offer a consumer-friendly approach to male fertility cater and are accessible to a broader demographic including men who are seeking supplemental or preventive products for early-stage infertility concerns. Due to ease of accessibility, the segment is poised for rapid growth as more males seek first line interventions such as vitamins, antioxidants, over the counter supplements. Additionally, availability of generic versions of fertility care drugs and supplements can be cost effective options for price conscious demographics boosting the segment’s growth.
Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay)
DNA fragmentation in male infertility market segment is projected to increase its revenue share during the forecast period due to rising awareness in males. It is an important biomarker for male infertility and healthcare professionals can tailor effective treatment plans by addressing underlying causes of DNA fragmentation. As early diagnosis demands for male fertility care grow, the demands for DNA fragmentation tests are poised to increase. Additionally, rising disposable income in emerging economies has made DNA fragmentation tests more accessible to males contributing to the segment’s growth. In July 2023, Medical Electronic Systems launched the QwikCheck DFI kit that is designed to make laboratory tests for DNA fragmentation quicker and easier.
Our in-depth analysis of the male infertility market includes the following segments
|
Distribution Channel |
|
|
Test |
|
|
Treatment |
|
North America Market Analysis
North America male infertility market is expected to capture revenue share of around 46.4% by the end of 2037. Innovations of ART have assisted the rapid growth in the market share of the region. A recent meta-analysis found that male fertility had declined by more than 50% in North America which has led to greater demands for male infertility care. A key market driver is the increasing awareness drives such as the National Infertility Awareness Week (NIAW) conducted by the American Society for Reproductive Medicine that help dispel stigma around male infertility care. The growing awareness opens access to male fertility care to a wider set of demographics which in turn assists the robust growth of the market.
The U.S. is at the forefront of the revenue boom in North America. The Centers for Disease Control (CDC) estimates the male infertility rate in the United States to be around 11.4% of men aged between 15 to 49 years between 2015 to 2019. CDCs report found that infertility had increased from 7.8% in ages 15-24 to 14.3% between 2015 to 2019. The increase in male infertility in the U.S. is leading to greater demand for male fertility care which helps the market’s growth. CDC’s report also indicated that male infertility has increased in married men compared to single and cohabiting men and social factors indicate that married men are more likely to seek fertility care. Additionally, the U.S. general fertility rate fell by 3% from 2022 as per a CDC report released in April 2024, which is poised to increase the government investments in awareness drives to combat the falling fertility rates.
Canada is a leading male infertility market in North America and profits from the region’s overall growth. The market in Canada benefits from the robust regulatory ecosystem for healthcare and the growing demands for male fertility care. Canada is witnessing trends where paternal age is increasing which may increase infertility cases. For instance, in April 2024, Institut de la Statistique du Québec published a report stating paternal age had increased to 33.8 in 2022 from 30.3 in 1976. Additionally, the report stated that men in their twenties are facing a decrease in fertility over the past decade. Such trends are projected to increase the demand for quality male fertility care in Canada during the forecast period.
Europe Market Analysis
Europe is poised to have profitable male infertility market growth during the forecast period owing to several factors such as the declining rate of birth, increasing cases of male infertility, awareness drives, and expansion of fertility preservation services. With the cases of cancer rising, the demand for male fertility preservation before treatment is increasing. In 2024, a study published in Oxford Academic stated that centers providing specialized crypto preservation of immature human testicular issues in Europe had increased in the last 20 years indicating a growing demand for male fertility care.
UK is poised to lead the male infertility market revenue share in Europe. UK is at the forefront of research on male infertility in Europe. For instance, in January 2022, Newcastle University published groundbreaking research showing new mutations during the reproduction process when the DNA of both parents is replicated can lead to infertility in men. Fertility awareness among the younger generations is increasing owing to a positive dissemination of information in social media channels regarding male infertility. The fertility index survey indicated that 11% of all men reported fertility issues with the highest concentration in the 18-24 age group in males. The rising cases and increasing awareness in younger demographics are poised to maintain the robust market growth in the UK.
Germany is expected to have a rapid increase in its revenue share during the forecast period. In December 2016, a researched published in Demographic Research indicated that fertility has decreased in German men compared to 1991 owing to various factors. The decline in sperm count of men in Europe in the past 50 years affects Germany and increases the demand for premium fertility care for men.
The male infertility market is competitive with global, regional, and local players vying for market share. Key market players in national and global markets are focusing on acquisitions, research and development, and product launches for early fertility care to increase their market revenue shares.
Some of the key players in the male infertility market are:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?